10-Q: HealthLynked Corp. Reports First Quarter 2024 Results with Revenue Decline and Increased Net Loss

Sentiment:

Quarterly Report


HealthLynked Corp. experienced a significant revenue decrease and an increased net loss in the first quarter of 2024, primarily due to reduced patient service revenue and the absence of a gain from discontinued operations.

Capital raiseThe company states that it plans to raise additional capital to fund its ongoing plan of operation.The company has substantial doubt about its ability to continue as a going concern without additional funding.The company has the right to sell up to 30,000,000 shares of its common stock to Yorkville under the SEPA, but the actual proceeds are uncertain.The company issued three new convertible notes payable to its CEO for $500,000 and refinanced an existing note for $166,500.The company sold 5,100,000 shares of common stock for $355,000 in private placements.
Worse than expectedThe company's net loss of $1.39 million is significantly worse than the net income of $1.45 million in the same period last year.The 43% decrease in total revenue is worse than expected, indicating significant challenges in the company's operations.The company's cash position and going concern warning indicate a worse financial situation than anticipated.

Summary

  • HealthLynked Corp. reported a net loss of $1.39 million for the quarter ended March 31, 2024, compared to a net income of $1.45 million for the same period in 2023.
  • Total revenue decreased by 43% year-over-year, from $1.76 million to $1.00 million, driven by a decline in patient service revenue, subscription revenue, and product revenue.
  • Patient service revenue fell by 43% to $963,621, primarily due to staffing changes at the NCFM and AEU practices.
  • Subscription revenue decreased by 53% to $7,628, and product revenue declined by 14% to $32,983.
  • Operating expenses decreased by 23% to $2.18 million, due to cost reduction efforts.
  • The company's loss from operations increased by 11% to $1.18 million.
  • The loss on extinguishment of debt was $96,660, and amortization of original issue discounts on notes payable was $108,265.
  • The company had a working capital deficit of $798,224 and an accumulated deficit of $43,420,854 as of March 31, 2024.
  • Cash used in operating activities was $854,855 for the quarter.
  • The company has substantial doubt about its ability to continue as a going concern without additional funding.

Sentiment

Score: 3

Explanation: The document presents a concerning financial picture with significant revenue decline, increased net loss, and a going concern warning. While there are some cost-cutting efforts, the overall sentiment is negative due to the company's financial instability and dependence on external funding.

Positives

  • Operating expenses decreased by 23% due to cost reduction efforts.
  • Selling, general and administrative costs decreased by 9% due to lower legal, consulting, and other overhead costs.
  • The company is actively working to replace departed physicians and expects patient service revenue to increase in future periods.

Negatives

  • Patient service revenue decreased by 43% due to staffing changes and the departure of key physicians.
  • Subscription revenue decreased by 53% due to a decrease in HealthLynked Network paid subscriptions.
  • The company reported a net loss of $1.39 million, a significant decrease compared to a net income of $1.45 million in the same period last year.
  • The company has a working capital deficit of $798,224 and an accumulated deficit of $43,420,854.
  • The company used $854,855 in cash from operating activities during the quarter.
  • There is substantial doubt about the company's ability to continue as a going concern without additional funding.

Risks

  • The company's ability to continue as a going concern is dependent on raising additional capital.
  • The company is subject to risks related to product development and generating revenue from its Digital Healthcare Division.
  • The company relies on a single supplier for the fulfillment of a substantial portion of its product sales.
  • The company's financial results are subject to uncertainty due to geopolitical events such as the Hamas-Israel and Russia-Ukraine conflicts.
  • The company's internal controls over financial reporting were deemed ineffective as of March 31, 2024.

Future Outlook

The company expects patient service revenue to increase in future periods as it adds an additional physician and continues patient marketing and retention efforts. The company plans to raise additional capital to fund its ongoing plan of operation and continue to invest in its Digital Healthcare business.

Management Comments

  • Management has evaluated the significance of the conditions described above in relation to the Company's ability to meet its obligations and concluded that, without additional funding, the Company will not have sufficient funds to meet its obligations within one year from the date the consolidated financial statements were issued.
  • Management considered the Company's current financial condition and liquidity sources, including current funds available, forecasted future cash flows and the Company's obligations due before May 15, 2025.

Industry Context

The healthcare industry is experiencing a shift towards digital solutions and integrated care models. HealthLynked's challenges in revenue generation and profitability highlight the competitive landscape and the need for effective marketing and sales strategies in the digital healthcare space. The company's reliance on a single supplier for medical supplies also presents a risk in the medical distribution sector.

Comparison to Industry Standards

  • Compared to other small-cap healthcare companies, HealthLynked's revenue decline of 43% is significant, indicating potential issues with market penetration or service delivery.
  • Many digital health companies are focusing on recurring revenue models, and HealthLynked's 53% decrease in subscription revenue is a concern.
  • Companies like Teladoc Health and Amwell, while much larger, are also facing challenges in profitability, but they have a more diversified revenue base and stronger cash positions.
  • HealthLynked's reliance on debt financing and the need for additional capital is a common challenge for early-stage healthcare companies, but the level of debt and the going concern warning are more severe than many peers.
  • The company's internal control weaknesses are also a concern, as many public companies in the healthcare sector have robust internal control frameworks.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Financial OfficerNADavid Rosal2024-03-11New hire

Legal Proceedings

  • The company is not aware of any legal proceedings that will have a material adverse effect on its business, financial condition, or operating results.

Related Party Transactions

  • The company issued three new convertible notes payable to its CEO, Dr. Michael Dent, for aggregate net cash proceeds of $500,000 and refinancing of an existing note in the amount of $166,500.
  • The company paid Dr. Dent's spouse $39,038 in consulting fees during the quarter.
  • Outside directors receive compensation equal to $20,000 in shares of restricted stock per annum.

Stakeholder Impact

  • Shareholders face significant risk due to the company's financial instability and the going concern warning.
  • Employees may be concerned about job security due to the company's financial challenges.
  • Customers may experience disruptions in service if the company's financial situation worsens.
  • Suppliers may face increased risk of non-payment due to the company's financial difficulties.
  • Creditors face increased risk of default due to the company's financial instability.

Next Steps

  • The company plans to raise additional capital to fund its ongoing plan of operation.
  • The company intends to continue to invest in its Digital Healthcare business, including the HealthLynked Network.
  • The company is marketing the HealthLynked Network by targeting large health systems, hospitals, and universities.
  • The company plans to leverage MOD's discounted medical supplies as an offering to its patient and physician members.
  • The company intends to utilize physician telesales through the use of telesales representatives as access to capital allows.

Key Dates

DateDescription
2014-08-04HealthLynked Corp. was incorporated in the State of Nevada.
2014-09-02The company filed Amended and Restated Articles of Incorporation.
2016-01-01The company adopted the 2016 Equity Incentive Plan.
2018-02-05The company increased the number of authorized shares of common stock to 500,000,000.
2021-09-09The company adopted the 2021 Equity Incentive Plan.
2022-07-05The company entered into a Standby Equity Purchase Agreement with Yorkville.
2023-01-17The company entered into the AHP Merger Agreement to sell its ACO/MSO Division.
2024-03-31End of the reporting period for the first quarter results.
2024-05-15Date of filing the quarterly report.

Keywords

HealthLynked, financial results, revenue decline, net loss, going concern, healthcare, digital health, medical distribution, operating expenses, capital raise

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.